Departamento de Genética e Evolução, Centro de Ciências Biológicas e da Saúde, Universidade Federal de São Carlos, São Carlos, Brazil.
Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
Pharmacol Res. 2022 Nov;185:106466. doi: 10.1016/j.phrs.2022.106466. Epub 2022 Sep 27.
Until recently it was thought that most humans only harbor one type of mitochondrial DNA (mtDNA), however, deep sequencing and single-cell analysis has shown the converse - that mixed populations of mtDNA (heteroplasmy) are the norm. This is important because heteroplasmy levels can change dramatically during transmission in the female germ line, leading to high levels causing severe mitochondrial diseases. There is also emerging evidence that low level mtDNA mutations contribute to common late onset diseases such as neurodegenerative disorders and cardiometabolic diseases because the inherited mutation levels can change within developing organs and non-dividing cells over time. Initial predictions suggested that the segregation of mtDNA heteroplasmy was largely stochastic, with an equal tendency for levels to increase or decrease. However, transgenic animal work and single-cell analysis have shown this not to be the case during germ-line transmission and in somatic tissues during life. Mutation levels in specific mtDNA regions can increase or decrease in different contexts and the underlying molecular mechanisms are starting to be unraveled. In this review we provide a synthesis of recent literature on the mechanisms of selection for and against mtDNA variants. We identify the most pertinent gaps in our understanding and suggest ways these could be addressed using state of the art techniques.
直到最近,人们还认为大多数人只携带一种线粒体 DNA(mtDNA),然而,深度测序和单细胞分析表明情况恰恰相反——混合的 mtDNA 群体(异质性)是常态。这很重要,因为在女性生殖系中传递过程中,异质性水平可能会发生剧烈变化,导致高水平导致严重的线粒体疾病。越来越多的证据表明,低水平的 mtDNA 突变会导致常见的迟发性疾病,如神经退行性疾病和心脏代谢疾病,因为随着时间的推移,遗传突变水平会在发育中的器官和非分裂细胞中发生变化。最初的预测表明,mtDNA 异质性的分离在很大程度上是随机的,水平增加或减少的趋势相等。然而,转基因动物实验和单细胞分析表明,在生殖系传递过程中和生命过程中的体组织中并非如此。在不同的情况下,特定 mtDNA 区域的突变水平可能会增加或减少,并且正在开始揭示潜在的分子机制。在这篇综述中,我们综合了最近关于 mtDNA 变体选择的机制的文献。我们确定了我们理解中最相关的差距,并提出了使用最先进的技术解决这些差距的方法。